Splicing factor SF3B4 promotes mitochondrial glutamine metabolism in hepatocellular carcinoma by regulating GLS1 isoform switching
Biochemical and Biophysical Research Communications · 2026
DOI: 10.1016/j.bbrc.2025.153134 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Seungyeon Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea; Institute for Aging and Metabolic…. Hauptthemen laut MEDLINE: Glutamine, Glutaminase, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Military Institute of Science and Technology, National Research Foundation of Korea.
Abstract (Originalsprache)
Metabolic reprogramming is a hallmark of cancer, enabling tumor cells to adapt to nutrient stress and sustain uncontrolled proliferation. In hepatocellular carcinoma (HCC), glutamine metabolism is markedly upregulated and plays a pivotal role in supporting tumor growth and survival. However, the molecular mechanisms underlying this metabolic shift remain poorly understood. Here, we identify the splicing factor SF3B4 as a key regulator of glutamine metabolism in HCC through its control of glutaminase 1 (GLS1) alternative splicing. SF3B4 is highly expressed HCC and is essential for tumor cell proliferation, migration and colony formation. Mechanistically, SF3B4 preferentially promotes the production of the GAC isoform of GLS1, which exhibits higher catalytic activity, while repressing the KGA isoform. Genetic or pharmacological inhibition of SF3B4 leads to reduced GAC expression, decreased GLS enzymatic activity, impaired glutaminolysis, and suppression of glutamine-driven mitochondrial respiration. Moreover, SF3B4 is required for tumor cell survival under glucose-deprived conditions, highlighting its role in supporting metabolic flexibility under nutrient stress. Collectively, these findings uncover a previously unrecognized function of SF3B4 in promoting mitochondrial glutamine metabolism in HCC and suggest that the SF3B4-GAC axis may represent a potential therapeutic target for glutamine-addicted liver cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea; Institute for Aging and Metabolic Diseases, College of Medicine, The Catholic University of Korea, Seou…
- Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, 06591, Republic of Korea; Department of Medical Science, Graduate School of the Catholic University of Korea, Seoul, 06591, Repub…
- Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.
Förderung
- Military Institute of Science and Technology
- National Research Foundation of Korea
Zitieren
APA
Yang, S., Ko, M., Zhang, W., & Jeong, S. M. (2026). Splicing factor SF3B4 promotes mitochondrial glutamine metabolism in hepatocellular carcinoma by regulating GLS1 isoform switching. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.153134
Vancouver
Yang S, Ko M, Zhang W, Jeong SM. Splicing factor SF3B4 promotes mitochondrial glutamine metabolism in hepatocellular carcinoma by regulating GLS1 isoform switching. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2025.153134
BibTeX
@article{Yang2026,
author = {Yang, Seungyeon and Ko, Minbeom and Zhang, Wei and Jeong, Seung Min},
title = {Splicing factor SF3B4 promotes mitochondrial glutamine metabolism in hepatocellular carcinoma by regulating GLS1 isoform switching},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
doi = {10.1016/j.bbrc.2025.153134}
}
EUVIMED